Allarity Therapeutics, Inc. (ALLR)
NASDAQ: ALLR · Real-Time Price · USD
0.990
-0.040 (-3.87%)
At close: Dec 20, 2024, 4:00 PM
1.010
+0.020 (2.00%)
After-hours: Dec 20, 2024, 7:50 PM EST
Allarity Therapeutics Employees
As of December 31, 2023, Allarity Therapeutics had 6 total employees, including 5 full-time and 1 part-time employees. The number of employees decreased by 3 or -33.33% compared to the previous year.
Employees
6
Change (1Y)
-3
Growth (1Y)
-33.33%
Revenue / Employee
n/a
Profits / Employee
-$3,237,167
Market Cap
4.39M
Employees Chart
Related Stocks
Company Name | Employees |
---|---|
Biomerica | 64 |
Healthcare Triangle | 31 |
Galmed Pharmaceuticals | 8 |
TNF Pharmaceuticals | 6 |
Oragenics | 5 |
Lixte Biotechnology Holdings | 4 |
Protagenic Therapeutics | 3 |
GT Biopharma | 2 |
ALLR News
- 15 days ago - Allarity Therapeutics, Inc. Investors: Please contact the Portnoy Law Firm to recover your losses. November 12, 2024 Deadline to file Lead Plaintiff Motion - GlobeNewsWire
- 4 weeks ago - Allarity Therapeutics Reports Key Progress in Phase 2 Stenoparib Trial and Strategic Corporate Advancements - GlobeNewsWire
- 5 weeks ago - DEADLINE REMINDER: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Allarity Therapeutics - Accesswire
- 5 weeks ago - DEADLINE TOMORROW: Allarity Therapeutics Inc Is Being Sued For Violating Securities Laws And Impacted Investors Are Invited To Reach Out To The Schall Law Firm - Accesswire
- 5 weeks ago - The Schall Law Firm Urges Shareholders In Allarity Therapeutics, Inc. To Join A Securities Fraud Case - Accesswire
- 6 weeks ago - Allarity Therapeutics Inc Is Being Sued For Violating Securities Laws And Investors With Losses Are Invited To Contact The Schall Law Firm - Accesswire
- 6 weeks ago - ALLR Deadline: Rosen Law Firm Urges Allarity Therapeutics, Inc. (NASDAQ: ALLR) Stockholders with Large Losses to Contact the Firm for Information About Their Rights - Business Wire
- 6 weeks ago - The Schall Law Firm Urges Shareholder Participation In A Securities Fraud Case Against Allarity Therapeutics, Inc. - Accesswire